The NYC Health Department is proposing that the Board amend Health Code §13.03(b)(3)(A) to require laboratories to report all hepatitis B virus (Hep B) DNA test results, including negative results - please comment!
Read and provide your comments on the NYC Department of Health proposed health code amendment on HCV reflex RNA testing.
NASTAD has issued a Call to Action for an urgent response to the nation's hepatitis C epidemic.
The letter urges support for increased funding for viral hepatitis in the FY2018 appropriations bills.
The FY 2017-18 NYC Viral Hep Budget Proposal supports building on the existing success of the City’s viral hepatitis programs, including Check Hep B and C Patient Navigation Program, and Hep C Peer Navigation Program.
This Consensus statement was adopted at the NYS Hep C Elimination Summit and provides a statewide plan to eliminate Hep C.
VOCAL-NY and Harm Reduction Coalition have released the Hep C 2017 State Budget and Legislative Platform.
The Action Plan’s goals guide individuals and organizations to strengthen the response to Hep B and C.
The letter will be sent to all United States Senators before they vote this week on a budget resolution that will pave the way for repeal of the Affordable Care Act.
NYS ADAP will be offering access to new Hep C meds, including Zepatier, Viekira pak, Viekira XR, and Daklinza.
